| Literature DB >> 31212627 |
Li Jia1,2, Tiantian Zuo3,4, Chunxia Zhang5,6, Weiwei Li7,8, Hongda Wang9,10, Ying Hu11,12, Xiaoyan Wang13,14, Yuexin Qian15,16, Wenzhi Yang17,18, Heshui Yu19,20.
Abstract
The flower buds of three Panax species (PGF: flower bud of P. ginseng; PQF: flower bud of P. quinquefolius; PNF: flower bud of P. notoginseng), widely consumed as healthcare products, are easily confused particularly in the extracts or traditional Chinese medicine (TCM) formulae. We are aimed to develop an untargeted metabolomics approach, by ultra-high performance liquid chromatography/ion mobility-quadrupole time-of-flight mass spectrometry (UHPLC/IM-QTOF-MS) to unveil the chemical markers diagnostic for the differentiation of PGF, PQF, and PNF. Key parameters affecting chromatographic separation and MS detection were optimized in sequence. Forty-two batches of flower bud samples were analyzed in negative high-definition MSE (HDMSE; enabling three-dimensional separations). Efficient metabolomics data processing was performed by Progenesis QI (Waters, Milford, MA, USA), while pattern-recognition chemometrics was applied for species classification and potential markers discovery. Reference compounds comparison, analysis of both HDMSE and targeted MS/MS data, and retrieval of an in-house ginsenoside library, were simultaneously utilized for the identification of discovered potential markers. Satisfactory conditions for metabolite profiling were achieved on a BEH Shield RP18 column and Vion™ IMS-QTOF instrument (Waters; by setting the capillary voltage of 1.0 kV and the cone of voltage 20 V) within 37 min. A total of 32 components were identified as the potential markers, of which Rb3, Ra1, isomer of m-Rc/m-Rb2/m-Rb3, isomer of Ra1/Ra2, Rb1, and isomer of Ra3, were the most important for differentiating among PGF, PQF, and PNF. Conclusively, UHPLC/IM-QTOF-MS-based metabolomics is a powerful tool for the authentication of TCM at the metabolome level.Entities:
Keywords: Panax; UHPLC/IM-QTOF-MS; chemical marker; flower bud; high-definition MSE; metabolomics
Mesh:
Year: 2019 PMID: 31212627 PMCID: PMC6600391 DOI: 10.3390/molecules24112188
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of 39 ginsenoside reference compounds.
Figure 2Selection of the stationary phase for the ultra-high performance liquid chromatography (UHPLC) separation of metabolites from the flower bud of P. ginseng, (PGF), the flower bud of P. quinquefolius (PQF), and the flower bud of P. notoginseng (PNF). The left shows the base peak chromatograms (BPC) obtained on ten candidate sub-2 µm particles packed columns and the right is the scatter plot of the resolved peaks.
Figure 3Optimization of two key ESI source parameters of the Vion IMS-QTOF high-resolution mass spectrometer by nine ginsenosides representative of five subclasses. Protopanaxatriol type (PPT): notoginsenoside R1 (noto-R1) and ginsenoside Re (Re); protopanaxadiol type (PPD): ginsenosides Rb1 (Rb1) and -Rd (Rd); oleanolic acid type (OA): ginsenoside Ro (Ro) and chikusetsusaponin IVa (IVa); octillol type (OT): 24(R)-pseudoginsenoside F11 (p-F11); malonylated: malonylfloralginsenoside Re1 (m-floral-Re1) and malonylginsenoside Rb1 (m-Rb1). Capillary voltage: 0.5–3.0 kV; cone voltage: 20–100 V.
Figure 4Optical photographs and base peak chromatograms of representative samples in the negative high-definition MSE (HDMSE) mode. PGF: flower bud of P. ginseng, PGF-12), PQF: flower bud of P. quinquefolius, PQF-8), and PNF: flower bud of P. notoginseng, PNF-9) Peaks identified by comparing with the reference compounds are annotated in base peak chromatograms with the numbers consistent with Figure 1.
Figure 5Comparison of the flower buds of Panax ginseng (PGF), P. quinquefolius (PQF), and P. notoginseng (PNF) by chemometrics. (A): score plot of OPLS-DA; (B) variable importance in projection (VIP) plot of 42 ions with a cutoff set at 3.0; (C) heat map plotted by species VS 20 differential ions.
Information of 32 ginsenoside markers for differentiating among PGF, PQF, and PNF. L: low level; M: medium level; H: high level.
| No. | VIP | tR (min) |
| CCS (Å2) | Identification | PGF | PQF | PNF |
|---|---|---|---|---|---|---|---|---|
| M1 | 8.59 | 24.76 | 1077.5881 | 357.30 | ginsenoside Rb3 | L | H | M |
|
| 7.84 | 22.09 | 1209.6274 | 355.12 | ginsenoside Ra1 | L | L | H |
| M3 | 6.97 | 27.74 | 1163.5880 | 370.72 | isomer of m-Rc/m-Rb2/m-Rb3 | L | M | H |
|
| 6.63 | 25.37 | 1209.6274 | 356.45 | isomer of ginsenoside Ra1/Ra2 | L | L | H |
| M5 | 6.53 | 19.71 | 1107.5973 | 350.29 | ginsenoside Rb1 | M | L | H |
|
| 6.43 | 17.52 | 1239.6379 | 283.47 | isomer of ginsenoside Ra3 | L | L | H |
|
| 5.25 | 19.42 | 1209.6274 | 358.21 | isomer of ginsenoside Ra1/Ra2 | L | L | H |
|
| 5.21 | 21.07 | 1209.6274 | 351.82 | isomer of ginsenoside Ra1/Ra2 | L | L | H |
|
| 5.06 | 20.97 | 1325.6383 | 368.56 | isomer of m-Ra3 | L | L | H |
|
| 4.61 | 22.80 | 1341.6696 | 379.05 | notoginsenoside Q/S or isomer | L | L | H |
| M11 | 4.46 | 29.77 | 1249.5896 | 358.00 | dimal-Rc/Rb2/Rb3 or isomer | L | H | M |
| M12 | 4.41 | 27.06 | 1163.5885 | 377.51 | isomer of m-Rc/m-Rb2/m-Rb3 | L | H | M |
|
| 4.33 | 16.82 | 1341.6696 | 372.35 | notoginsenoside Q/S or isomer | L | L | H |
| M14 | 4.00 | 25.70 | 1163.5880 | 347.14 | isomer of m-Rc/m-Rb2/m-Rb3 | L | M | H |
| M15 | 3.85 | 25.83 | 1193.5976 | 357.85 | isomer of m-Rb1 | H | M | L |
| M16 | 3.84 | 25.12 | 1163.5878 | 337.60 | isomer of m-Rc/m-Rb2/m-Rb3 | M | M | H |
|
| 3.82 | 26.37 | 1295.6327 | 365.60 | m-Ra2 or isomer | L | L | H |
| M18 | 3.79 | 30.19 | 1249.5886 | 365.80 | dimal-Rc/Rb2/Rb3 or isomer | L | H | M |
| M19 | 3.78 | 26.75 | 1163.5880 | 337.60 | m-Rb3 | L | H | M |
|
| 3.76 | 19.54 | 1341.6696 | 375.59 | notoginsenoside Q/S or isomer | L | L | H |
| M21 | 3.72 | 5.35 | 695.1473 | 229.84 | m-kaempferol-GlcGlc | M | H | L |
| M22 | 3.51 | 29.51 | 1163.5880 | 371.94 | isomer of m-Rc/m-Rb2/m-Rb3 | M | H | L |
| M23 | 3.50 | 21.91 | 1077.5879 | 338.39 | ginsenoside Rc | L | M | H |
|
| 3.37 | 17.89 | 815.4830 | 301.49 | ginsenoside F3 | H | L | L |
|
| 3.36 | 18.71 | 1209.6274 | 351.14 | isomer of ginsenoside Ra1/Ra2 | L | L | H |
| M26 | 3.33 | 23.90 | 1077.5879 | 360.22 | ginsenoside Rb2 | M | H | M |
|
| 3.29 | 29.13 | 793.4395 | 282.26 | chikusetsusaponin IVa | M | H | L |
|
| 3.21 | 19.55 | 716.3369 | 354.60 | unknown | L | L | H |
|
| 3.20 | 13.10 | 845.4921 | 298.26 | 24( | L | H | L |
|
| 3.11 | 14.72 | 1371.6802 | 386.06 | notoginsenoside D/T or isomer | L | L | H |
| M31 | 3.09 | 15.00 | 845.4921 | 302.65 | ginsenoside Rf | H | L | M |
|
| 3.03 | 23.72 | 1295.6327 | 362.76 | m-Ra2 or isomer | L | L | H |
*: Considered as the characteristic components.
Figure 6Structural elucidation of four marker compounds based on the negative CID-MS2 data. M1 (Rb3) and M5 (Rb1) was identified with the aid of reference compounds.
Figure 7Box charts illustrating the distribution difference of the six most important marker compounds among PGF, PQF, and PNF. M2, M4, and M6 can be the characteristic components of PNF.